BM635 - Bacterial 抑制剂 - MedChemExpress_第1页
BM635 - Bacterial 抑制剂 - MedChemExpress_第2页
BM635 - Bacterial 抑制剂 - MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEBM635Cat. No.: HY-109587CAS No.: 1493762-74-5分式: CHFNO分量: 392.51作靶点: Bacterial作通路: Anti-infection储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 31 mg/mL (78.98 mM; Need ultrasonic and warm

2、ing)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 2.5477 mL 12.7385 mL 25.4771 mL5 mM 0.5095 mL 2.5477 mL 5.0954 mL10 mM 0.2548 mL 1.2739 mL 2.5477 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 BM635MmpL3 的抑制剂, 具有出的抗分歧杆菌活性。抑制结合分歧杆菌H37Rv的MIC50 值为0.12 M。IC50 & Target MIC50:

3、 0.12 M (M. tuberculosis H37Rv) 1体内研究BM635 has potent MIC (0.12 M), Tox50:MIC ratio of 100, and good microsomal stability in mice (1.4mL/min/g). When tested in an acute murine infection model at multiple doses, BM635 exhibits potent anti-1/2 Master of Small Molecules 您边的抑制剂师www.MedChemEtubercular ac

4、tivity, with an ED99 of 49 mg/Kg (IC95%: 4354 mg/Kg) 1. The half-life in vivo of BM635 is 1h,allowing a reasonable maximum concentration (Cmax=1.62 M) and a moderate bioavailability (46%). Itspoor aqueous solubility together with its high lipophilicity leads to low exposure in vivo 2.PROTOCOLCell As

5、say The measurement of the minimum inhibitory concentration (MIC) for each tested compounds (includingBM635) are performed in 96 wells flat-bottom, polystyrene microtiter plates. Ten two-fold drug dilutions inneat DMSO starting at 200 M are performed. Five L of these drug solutions are added to 95 L

6、 ofMiddlebrook 7H9 medium. Isoniazid is used as a positive control, 8 two-fold dilutions of Isoniazid starting at160 g/mL are prepared and 5 L of this control curve is added to 95 L of Middlebrook 7H9 medium. FiveL of neat DMSO are added 95 L of Middlebrook 7H9 medium in row 12 (growth and Blank con

7、trols). Theinoculum is standardized to approximately 1107 cfu/mL and diluted 1 in 100 in Middlebrook 7H9 broth toproduce the final inoculum of H37Rv strain. One hundred L of this inoculum is added to the entire plate butG-12 and H-12 wells (Blank controls). All plates are placed in a sealed box to p

8、revent drying out of theperipheral wells and they are incubated at 37C without shaking for six days. A resazurin solution is preparedby dissolving one tablet of resazurin in 30 mL sterile PBS (phosphate buffered saline). Of this solution, 25 Lare added to each well. Fluorescence is measured after 48

9、 hours to determine the MIC value 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mouse: Nine (one per dose) 8-10 week old B6 female mice are infected by intratracheal route with 105CFUAdministration H37Rv per mouse suspended in 50 L phosphate

10、buffer saline. BM635 is administered once a day at ninedoses ranging from 40 to 300 mg/kg from day 1 to day 8 after infection, and 24 hours after the last dose themice are sacrificed. To measure the infection burden in lungs, all lobes are aseptically removed andhomogenized. The homogenates are supp

11、lemented with 5% glycerol and stored frozen (80C) until plating.Plates (10%OADC-7H11 medium) are incubated for 14 days at 37C 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Poce G, et al. Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection. PLoS One.2013;8(2):e56980.2. Poce G, et al. Pharmaceutical salt of BM635 with improved bioavailability. Eur J Pharm Sci. 2017 Mar 1;99:17-23.McePdfHeightCaution: Produc

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

最新文档

评论

0/150

提交评论